| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 263.27B | 251.37B | 226.71B | 228.06B | 207.97B | 209.12B |
| Gross Profit | 121.47B | 116.54B | 104.78B | 106.80B | 101.09B | 87.75B |
| EBITDA | 76.02B | 74.55B | 66.11B | 67.84B | 64.45B | 55.97B |
| Net Income | 45.35B | 43.04B | 38.03B | 41.09B | 38.78B | 33.47B |
Balance Sheet | ||||||
| Total Assets | 322.24B | 330.76B | 323.46B | 298.71B | 279.69B | 265.51B |
| Cash, Cash Equivalents and Short-Term Investments | 34.27B | 27.45B | 22.74B | 29.65B | 34.66B | 32.38B |
| Total Debt | 26.10B | 40.47B | 40.98B | 27.29B | 22.71B | 22.67B |
| Total Liabilities | 80.87B | 94.58B | 92.56B | 77.19B | 71.68B | 64.95B |
| Stockholders Equity | 238.01B | 233.29B | 227.47B | 218.42B | 205.91B | 198.83B |
Cash Flow | ||||||
| Free Cash Flow | 45.87B | 43.01B | 12.70B | 15.05B | 29.10B | 30.40B |
| Operating Cash Flow | 61.74B | 59.18B | 33.70B | 35.23B | 41.95B | 39.94B |
| Investing Cash Flow | -18.65B | -17.61B | -18.74B | -19.64B | -12.39B | -12.85B |
| Financing Cash Flow | -39.60B | -35.65B | -22.10B | -25.03B | -27.87B | -25.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥735.02B | 16.33 | 19.69% | 3.18% | 10.06% | 18.03% | |
72 Outperform | ¥1.09T | 101.46 | 1.67% | 1.00% | -1.90% | -71.97% | |
71 Outperform | ¥741.59B | 18.35 | 4.79% | 4.25% | -1.21% | -27.21% | |
68 Neutral | ¥1.19T | 10.85 | 1.09% | 3.54% | -11.50% | 25.86% | |
66 Neutral | ¥720.15B | 8.49 | 8.79% | 2.70% | -1.64% | ― | |
62 Neutral | ¥484.86B | 62.55 | 1.08% | 3.40% | -1.94% | -84.08% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Nissan Chemical Corporation reported a 10.1% increase in net sales for the six months ending September 30, 2025, compared to the same period in the previous year. The company’s financial results indicate a positive trajectory with increased net income and a revised dividend outlook, suggesting strengthened financial health and potential benefits for stakeholders.
Nissan Chemical Corporation announced the cancellation of 1,000,000 of its common shares, representing 0.73% of its issued shares, as decided in a Board of Directors meeting. This move is part of the company’s capital management strategy, potentially impacting shareholder value and market perception by reducing the number of outstanding shares.